Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia

被引：0
|
作者：
Batra, R. [1 ]
Weisenburger, D. [1 ]
Snyder, D. [1 ]
Bedell, V. [1 ]
Murata-Collins, J. [1 ]
Gaal, K. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1380
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [41] Acquired Cytogenetic Aberrations in Philadelphia Chromosome Negative Cells from Patients with Chronic Myelogenous Leukemia Not Associated with Definitive Myelodysplasia.
    Bulkeley, W. W.
    Shah, B.
    Zhang, X.
    Pinilla-Ibarz, J.
    Zhang, L.
    MODERN PATHOLOGY, 2011, 24 : 287A - 288A
  • [42] ADDITIONAL CHROMOSOMAL ABNORMALITIES IN PHILADELPHIA-POSITIVE CHRONIC MYELOID LEUKEMIA PATIENTS APPEARING DURING THERAPY WITH TYROSINE KINASE INHIBITORS
    Bennour, A.
    Tabka, I.
    Ouahchi, I.
    Elloumi, M.
    Meddeb, B.
    Khelif, A.
    Saad, A.
    Sennana, H.
    HAEMATOLOGICA, 2014, 99 : 595 - 595
  • [43] PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA - A MORPHOLOGICAL REASSESSMENT
    PUGH, WC
    PEARSON, M
    VARDIMAN, JW
    ROWLEY, JD
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (03) : 457 - 467
  • [44] Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment
    Issa, Ghayas C.
    Kantarjian, Hagop M.
    Gonzalez, Graciela Nogueras
    Borthakur, Gautam
    Tang, Guilin
    Wierda, William
    Sasaki, Koji
    Short, Nicholas J.
    Ravandi, Farhad
    Kadia, Tapan
    Patel, Keyur
    Luthra, Raja
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Rios, Mary Beth
    Dellasala, Sara
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2017, 130 (19) : 2084 - 2091
  • [45] Pediatric Chronic Myelogenous Leukemia in Tyrosine Kinase Inhibitor Era
    Rich, Amy
    Ai, Di
    Wang, Wei
    You, M. James
    Yin, C. Cameron
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffery
    Hu, Shimin
    LABORATORY INVESTIGATION, 2015, 95 : 373A - 373A
  • [46] Pediatric Chronic Myelogenous Leukemia in Tyrosine Kinase Inhibitor Era
    Rich, Amy
    Ai, Di
    Wang, Wei
    You, M. James
    Yin, C. Cameron
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffery
    Hu, Shimin
    MODERN PATHOLOGY, 2015, 28 : 373A - 373A
  • [47] Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia
    Samis, Jill
    Lee, Paul
    Zimmerman, Donald
    Arceci, Robert J.
    Suttorp, Meinolf
    Hijiya, Nobuko
    PEDIATRIC BLOOD & CANCER, 2016, 63 (08) : 1332 - 1338
  • [48] Tyrosine kinase inhibitor therapy for acute myeloid leukemia with late-appearing Philadelphia chromosome
    Aoki, Jun
    Kakihana, Kazuhiko
    Kobayashi, Takeshi
    Hirashima, Yuka
    Akiyama, Hideki
    Ohashi, Kazuteru
    Sakamaki, Hisashi
    LEUKEMIA RESEARCH, 2012, 36 (01) : E41 - E42
  • [49] Chromosomal abnormalities in Philadelphia chromosome (Ph) negative metaphases appearing during treatment with imatinib mesylate in patients (pts) with Ph positive chronic myeloid leukemia (CML) in chronic phase (CP).
    Medina, J
    Kantarjian, H
    Talpaz, M
    O'Brien, S
    Garcia-Manero, G
    Faderl, S
    Giles, F
    Rios, MB
    Hayes, K
    Cortes, J
    BLOOD, 2002, 100 (11) : 368A - 368A
  • [50] A CHROMOSOME SURVEY OF 42 CASES OF CHRONIC MYELOGENOUS LEUKEMIA - SIGNIFICANCE OF THE PHILADELPHIA TRANSLOCATION
    OHYASHIKI, K
    ACTA HAEMATOLOGICA JAPONICA, 1984, 47 (04): : 972 - 981
12345